Drug Trial Radar · NCT00389675
DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension
Last checked: Nov 20, 2026Latest source record: Jan 6, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
661
Actual
Start
May 2007
Primary completion
Feb 2010
Study completion May 2010
Sponsor
- Lead sponsor
- Gilead SciencesGilead Sciences (GILD)
- Sponsor type
- Industry
- First posted
- Oct 19, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 35 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a double-blind, active-controlled, long-term study of a new experimental drug called darusentan. Darusentan in not currently approved by the United States Food and Drug Administration (FDA), which means that a doctor cannot prescribe this drug. The purpose of this study is to evaluate the long-term safety of darusentan (optimized dose) as compared to an active control, administered orally.
Conditions
- Hypertension
Interventions
DarusentanDrug
Darusentan capsules at a dose of 50, 100, or 300 mg administered orally once daily
GuanfacineDrug
Guanfacine 1 mg capsules administered orally once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in mean 24-hour systolic and diastolic ambulatory blood pressureTime frame: Baseline to Week 14
- Percentage of subjects who reach systolic blood pressure goalTime frame: Week 14
- Change from baseline in estimated glomerular filtration rate (eGFR)Time frame: Baseline to Week 14
Locations
99 sites in 4 countries. Site status is shown where the registry gives one.
Alabama Internal Medicine, PC
Birmingham, Alabama
Greystone Medical Research, LLC
Birmingham, Alabama
The Heart Center, PC
Huntsville, Alabama
Mulberry Medical Associates, PC
Montgomery, Alabama
Arizona Center for Clinical Research
Glendale, Arizona
Cardiovascular Consultants, Ltd.
Glendale, Arizona
Lovelace Scientific Resource, Inc.
Phoenix, Arizona
Cochise Clinical Research
Sierra Vista, Arizona
Southwest Heart
Tucson, Arizona
HealthFirst Physicians of AR, PA dba Convenient Care Clinic
Hot Springs, Arkansas
NEA Clinical
Jonesboro, Arkansas
Arkansas Primary Care Clinic, PA
Little Rock, Arkansas
Medical Investigators, Inc.
Little Rock, Arkansas
Highgrove Medical Center
Bakersfield, California
Central Cardiology Medical Clinic
Bakersfield, California
Impact Clinical Trials
Beverly Hills, California
VA Greater Los Angeles Healthcare System
Los Angeles, California
Rancho Cucamonga Clinical Trials
Rancho Cucamonga, California
Pacific Heart Institute
Santa Monica, California
Los angeles biomedical research Institute at Harbor-UCLA Medical Center
Torrance, California
Aurora Denver Cardiology Associates
Aurora, Colorado
Aurora Denver Cardiology Associates
Denver, Colorado
Clinical Research of South Florida
Coral Gables, Florida
Doctors Medical center of Walton County
DeFuniak Springs, Florida
Broward General Medical Center
Fort Lauderdale, Florida
Maxine Hamilton, MD, PA
Fort Lauderdale, Florida
St John's Center for Clinical Research
Jacksonville, Florida
Private Practice of Dr. Bridget Bellingar
Largo, Florida
A + Research Inc.
Miami, Florida
AppleMed Research, Inc.
Miami, Florida
Internal Medicine Associates of South Florida
North Miami Beach, Florida
Ormond Medical Arts Pharmaceutical Research Center
Ormond Beach, Florida
Nothwest Florida Heart Group, PA-Research Dept
Pensacola, Florida
Cardiovascular Center of Sarasota
Sarasota, Florida
Suncoast Cardiovascular Research, Inc
St. Petersburg, Florida
Tampa Bay Nephrology Associates, PL
Tampa, Florida
Orlando Rangel, MD, PA
Tampa, Florida
AMR Research Associates, LLC
Bogart, Georgia
Atlanta Vascular Research Foundation
Tucker, Georgia
Consultants in Cardiovascular Med (CIS)
Melrose Park, Illinois
Showing 40 of 99 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.